Dried Blood Spot Collection Cards Market to Reach USD 337.3 Million by 2026
The global dried blood spot collection cards market size was estimated at USD 257.3 million in 2018 and is anticipated grow at a CAGR of 3.5% over the forecast period.
(firmenpresse) - The global dried blood spot collection cards market size is expected to reach USD 337.3 million by the year 2026, expanding at a CAGR of 3.5%, according to a new report by Grand View Research, Inc. Key drivers of the market include an increase in the use of dried blood spot (DBS) cards in newborn screening and for serological diagnostics of infectious and autoimmune diseases, among other applications.
Use of DBS cards in newborn screening is expected to boost market growth during the forecast period. According to NIH, it is estimated that around 4 million infants were screened in the U.S. in 2017. Additionally, data from the CDC indicates that about 12,500 infants were diagnosed with congenital diseases that were detected through newborn screening tests. This states that almost 1 out of every 300 infants screened were eventually diagnosed with one of the congenital diseases.
Therefore, increasing awareness has facilitated a rise in demand for DBS cards for the detection of congenital diseases in infants which is anticipated to fuel the market growth during the forecast period.
The usage of DBS for serological diagnostics of infectious or autoimmune diseases is also anticipated to fuel the market growth during the forecast period. DBS offers a cost-effective solution for diagnosis of infectious diseases as these collection cards can be easily collected, transported and preserved in settings with minimal infrastructural facilities. Global health settings, especially in the rural areas, lack the necessary infrastructure for quality assured venipuncture sparks significant interest in the usage of DBS cards for diagnosis of infectious or autoimmune diseases.
Various initiatives and strategic collaborations are expected to further drive dried blood spot collection cardsmarket growth. For instance, in February 2019, Health PEI announced the launch of its first blood spot testing clinic for hepatitis C and HIV. In the recent past, Health PEI partnered with PEERS Alliance in order to offer new hepatitis C clinics. Also, in July 2017, AIDS PEI announced the launch of free hepatitis C tests on World Hepatitis Day. Public Health England offers a national dried blood spot testing service for newborns born to hepatitis B positive mothers. This service provided by PHE is free and has been specially designed to improve the coverage of follow up testing for newborns of hepatitis B positive mothers. Similarly, in October 2019, World Anti-Doping Agency signed an agreement with 7 anti-doping agencies that include the U.S. Anti-Doping Agency (USADA) to explore the viability of DBS testing as part of its anti-doping tool kit. The objective of this project was to develop guidelines for the transport, collection, storage, and analysis of DBS. This method will be implemented at the 2020 Tokyo Summer Olympics. The usage of DBS in these settings offer several advantages such as; the presence of a phlebotomist to administer the test and the samples do not require a temperature-controlled environment. These are less invasive and are simpler than intravenous blood testing. Thus, the rise in government initiatives to enhance the usage of DBS is witnessed to propel the market growth during the forecast period.
In August 2017, PerkinElmer launched PerkinElmer Genetics'' clinical genomics services. Whole exome sequencing and whole-genome sequencing were offered in all their laboratories across India, U.S., and China. PerkinElmerge of DBS cards for newborn screening during the forecast period.
Further Key Findings from the Report Suggest:
Themen in dieser Pressemitteilung:
dried-blood-spot-collection-cards
dried-blood-cards
dried-blood-spot-collection
dried-blood-collection
blood-spot-collection-cards
blood-collection-cards
blood-collection
blood
medical
clinical
diagnosis
disgnostics
Unternehmensinformation / Kurzprofil:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales(at)grandviewresearch.com
For More Information: www.grandviewresearch.com
Datum: 16.03.2020 - 05:26 Uhr
Sprache: Deutsch
News-ID 1556854
Anzahl Zeichen: 5118
contact information:
Contact person:
Town:
San Francisco
Phone: Grand View Research, Inc.
Kategorie:
Pharmaceuticals & Biotech
Typ of Press Release: Financial
type of sending: send
Date of sending: 16.03.2020
Anmerkungen:
Diese Pressemitteilung wurde bisher 368 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Dried Blood Spot Collection Cards Market to Reach USD 337.3 Million by 2026
"
steht unter der journalistisch-redaktionellen Verantwortung von
Grand View Research, Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).